These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1700851)

  • 1. Development of a mitoxantrone-resistant P 388 in vivo: approaches to overcome resistance.
    Fichtner I; Becker M; Lemm M; Winterfeld G
    Oncology; 1990; 47(6):508-15. PubMed ID: 1700851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
    Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M
    Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo characterization of immunogenicity of a mitoxantrone-resistant murine P388 leukemia.
    Fichtner I; Reipert B; Becker M; Lemm M
    In Vivo; 1993; 7(1):73-9. PubMed ID: 8504210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-resistance of menogaril and mitoxantrone in a subline of P388 leukemia resistant to doxorubicin.
    Chandrasekaran B; Dimling J; Capizzi RL
    Cancer Treat Rep; 1987 Feb; 71(2):195-6. PubMed ID: 2948640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of non-P-glycoprotein multidrug-resistant Ehrlich ascites tumour cells selected for resistance to mitoxantrone.
    Nielsen D; Eriksen J; Maare C; Litman T; Kjaersgaard E; Plesner T; Friche E; Skovsgaard T
    Biochem Pharmacol; 2000 Aug; 60(3):363-70. PubMed ID: 10856431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoclopramide and nitrendipine are unable to enhance cytotoxicity of mitoxantrone in sensitive and resistant murine leukemias in vivo.
    Potemski P; Polakowski P
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):249-53. PubMed ID: 9597095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo response of mitoxantrone and doxorubicin with dipyrone in parental and doxorubicin-resistant P388 leukemia.
    Kamath NS; Chitnis MP
    Oncology; 1990; 47(2):166-9. PubMed ID: 2314829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.
    Taylor CW; Dalton WS; Parrish PR; Gleason MC; Bellamy WT; Thompson FH; Roe DJ; Trent JM
    Br J Cancer; 1991 Jun; 63(6):923-9. PubMed ID: 1676902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
    J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
    J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-resistance of vincristine-resistant sublines of P388 leukemia to mitoxantrone with special emphasis on the relationship between in vitro and in vivo cross-resistance.
    Inaba M; Nagashima K; Sakurai Y
    Gan; 1984 Jul; 75(7):625-30. PubMed ID: 6468847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of doxorubicin and cisplatin resistance in vivo in murine leukemias by the calcium antagonist RO 11-2933.
    Mazzoni A; Canti G
    Sel Cancer Ther; 1990; 6(4):167-76. PubMed ID: 2094936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.
    Hrubisko M; Balázová E; Kiss F; Kovácová J; Ujházy V
    Neoplasma; 1989; 36(6):651-7. PubMed ID: 2615869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].
    Donenko FV; Sitdikova SM; Kabieva AO
    Biull Eksp Biol Med; 1993 Sep; 116(9):309-11. PubMed ID: 8118011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of in vitro chemosensitivity by extracellular Ca++ in adriamycin sensitive and resistant P388 leukemic cells.
    Adwankar MK; Chitnis MP
    Neoplasma; 1990; 37(1):31-6. PubMed ID: 2320178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM; Goldenberg S; Gottesman MM; Hait WN
    Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome mediated gene transfer of drug resistance to mitoxantrone.
    Hazlehurst LA; Gros P; Dalton WS
    Anticancer Res; 1998; 18(2A):1005-10. PubMed ID: 9615755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo characterization of P388 leukemia resistant to mitomycin C.
    Rose WC; Huftalen JB; Bradner WT; Schurig JE
    In Vivo; 1987; 1(1):47-52. PubMed ID: 2979764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential alteration of cellular lipids in drug sensitive and resistant P388 leukemia cells by clofibrate: effects on mitoxantrone cytotoxicity.
    Parekh H; Chitnis M
    Tumori; 1991 Apr; 77(2):105-11. PubMed ID: 2048221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic activity of mitoxantrone and its biological interactions in parental and multidrug resistant subline of P388 murine leukemia cells.
    Chavan S; Parekh H; Chitnis M
    Neoplasma; 1992; 39(1):49-57. PubMed ID: 1528304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.